Financials Societal CDMO, Inc.

Equities

SCTL

US75629F1093

Pharmaceuticals

Market Closed - Nyse 04:00:00 2024-04-05 pm EDT 5-day change 1st Jan Change
1.1 USD +0.92% Intraday chart for Societal CDMO, Inc. 0.00% +213.84%

Valuation

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Capitalization 1 152.5 416.6 67.39 79.71 126 36.73
Enterprise Value (EV) 1 178.2 508.3 153.7 158 155.2 70.99
P/E ratio -1.82 x -23.3 x -2.46 x -6.58 x -4.34 x -2.5 x
Yield - - - - - -
Capitalization / Revenue 1.97 x 4.2 x 1.01 x 1.06 x 1.4 x 0.39 x
EV / Revenue 2.3 x 5.12 x 2.31 x 2.1 x 1.72 x 0.75 x
EV / EBITDA -4.76 x 14.9 x 750 x 17.2 x 18.1 x 13.3 x
EV / FCF -2.97 x -24.1 x 35.1 x 23.2 x -12.9 x -7.41 x
FCF Yield -33.7% -4.15% 2.85% 4.31% -7.72% -13.5%
Price to Book -7.94 x -63.7 x -5.78 x 1.9 x 2.27 x 0.63 x
Nbr of stocks (in thousands) 21,477 22,730 23,645 46,615 84,542 104,788
Reference price 2 7.100 18.33 2.850 1.710 1.490 0.3505
Announcement Date 2/19/19 3/4/20 2/26/21 3/1/22 3/1/23 3/22/24
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net sales 1 77.35 99.22 66.5 75.36 90.21 94.64
EBITDA 1 -37.41 34.15 0.205 9.191 8.597 5.335
EBIT 1 -45.26 25.75 -8.342 1.623 0.279 -3.573
Operating Margin -58.52% 25.95% -12.54% 2.15% 0.31% -3.78%
Earnings before Tax (EBT) 1 -62.29 4.625 -27.5 -11.37 -18.78 -13.14
Net income 1 -79.72 -18.63 -27.5 -11.37 -19.88 -13.27
Net margin -103.07% -18.78% -41.36% -15.09% -22.04% -14.03%
EPS 2 -3.900 -0.7850 -1.160 -0.2600 -0.3435 -0.1400
Free Cash Flow 1 -60.09 -21.12 4.374 6.803 -11.99 -9.581
FCF margin -77.69% -21.28% 6.58% 9.03% -13.29% -10.12%
FCF Conversion (EBITDA) - - 2,133.6% 74.01% - -
FCF Conversion (Net income) - - - - - -
Dividend per Share - - - - - -
Announcement Date 2/19/19 3/4/20 2/26/21 3/1/22 3/1/23 3/22/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2020 2021 2022 2023
Net Debt 1 25.7 91.7 86.3 78.3 29.2 34.3
Net Cash position 1 - - - - - -
Leverage (Debt/EBITDA) -0.6878 x 2.685 x 421.1 x 8.52 x 3.398 x 6.421 x
Free Cash Flow 1 -60.1 -21.1 4.37 6.8 -12 -9.58
ROE (net income / shareholders' equity) -1,706% -35.3% 264% -81.3% -39% -22.4%
ROA (Net income/ Total Assets) -16.6% 12.1% -4.88% 0.77% 0.11% -1.44%
Assets 1 481.5 -154 564.1 -1,478 -18,123 924.1
Book Value Per Share 2 -0.8900 -0.2900 -0.4900 0.9000 0.6600 0.5600
Cash Flow per Share 2 1.770 0.8200 0.8300 0.5400 0.1800 0.0800
Capex 1 10.5 8.34 7.6 5.29 8.35 8.24
Capex / Sales 13.61% 8.41% 11.43% 7.02% 9.26% 8.7%
Announcement Date 2/19/19 3/4/20 2/26/21 3/1/22 3/1/23 3/22/24
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Equities
  3. SCTL Stock
  4. Financials Societal CDMO, Inc.